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Two General Methods for the Isolation
of Enzyme Activities by Colony Filter Screening
allows 106 clones to be assayed simultaneously. The
usefulness of these methods at library level yet has to
be demonstrated [12, 15].
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method for the isolation of enzymatic activities from aWinterthurerstrasse 190
CH-8057 Zurich large repertoire of protein variants based on a filter-
sandwich assay. Filter screening techniques have provenSwitzerland
to be a valuable tool for isolating good-quality mono-
clonal antibodies from a large synthetic antibody reper-
toire expressed in bacterial cells [16–20]. We proposedSummary
that the filter sandwich screening technique could also
be applied to enzymes. The principle of the methodologyWe describe two general methodologies, based on
is depicted in Figure 1. Escherichia coli cells expressingfilter-sandwich assays, for isolating enzymatic activi-
enzyme are grown on a porous master filter receivingties from a large repertoire of protein variants ex-
nutrients from an agar plate by diffusion (Figure 1A). Thepressed in the cytoplasm of E. coli cells. The enzymes
enzyme of interest is expressed in the cytoplasm ofare released by the freezing and thawing of bacterial
bacterial cells and does not diffuse in the master filter.colonies grown on a porous master filter and diffuse
This porous filter, loaded with bacterial colonies, is thento a second “reaction” filter that closely contacts the
laid on top of a second filter (termed “reaction filter”).master filter. Reaction substrates can be immobilized
Enzymes are released from the bacterial cells by freez-either on the filter or on the enzyme itself (which is
ing and thawing and can then convert suitable sub-then, in turn, captured on the reaction filter). The re-
strates on the reaction filter (Figures 1B and 1C). Wesulting products are detected with suitable affinity re-
used a biotin ligase (BirA) as a model enzyme. BirAagents. We used biotin ligase as a model enzyme to
catalyzes the formation of biotinyl-5-adenylate from bi-assess the performance of the two methodologies.
otin and ATP. The first reaction is followed by a covalentActive enzymes were released by the bacteria, locally
attachment of biotin onto a specific lysine residue of abiotinylated the immobilized target substrate peptide,
peptide [21, 22]. However, the method is applicable toand allowed the sensitive and specific detection of
all enzymatic reactions in which the enzyme can beindividual catalytically active colonies.
expressed in bacteria and in which the substrate can
be chemically modified with a linker arm [11]. The enzy-
Introduction matic activity of the secreted enzyme is assayed by
two different approaches, shown in Figure 2. In the first
Having implications of both scientific and industrial na- approach (Figures 1B and 2A), the reaction filter is
ture, the isolation of improved enzymes is an important coated with the reaction substrate (in this case the biotin
challenge in protein engineering. Directed evolution has acceptor peptide [BAP]). The peptide is biotinylated if
proven to be a powerful route to enhancing the stability, it comes in contact with active biotin ligase secreted
catalytic efficiency, or substrate specificity of enzymes from cells on the master filter. In the second approach
[1]. Construction of libraries of mutant enzymes by vari- (Figures 1C and 2B), the reaction filter is coated with
ous mutagenesis techniques [2–4] followed by screen- human serum albumin (HSA). The enzyme is expressed
ing has led to the isolation of remarkable enzyme vari- as a fusion protein of BirA, calmodulin, and the albumin
ants [5]. In most of these screening strategies, the binding domain (ABD) and is immobilized noncovalently
enzyme is assayed intracellularly by linking of the enzy- but in a stable fashion (koff  103 s1) on the reactionmatic reaction to a growth or survival advantage to the filter by binding of the ABD to human serum albumin
host organism [6–8]. These in vivo screening methods (HSA) [23–26]. The biotin acceptor peptide (which repre-
have the disadvantage that the enzymatic reaction of sents the substrate) linked to a high-affinity calmodulin
interest can interfere with the cellular metabolism and binding peptide (kd  2 pM; [27]) is then immobilized bythat the choices of parameters for solvent or substrate binding to calmodulin and can be biotinylated by the
are limited. Assays performed in microtiter plates allow enzyme [11]. The product of the reaction, a biotinylated
in vitro screening of enzyme activities. However, these peptide, is detected with a streptavidin-horseradish per-
assays are limited by the number of wells used to mea- oxidase conjugate.
sure the catalytic performance with chromogenic or flu-
orogenic substrates [9]. Tawfik et al. [10] have devised
a sensitive method, catELISA, based on the catalytic Results
conversion of substrates into products, to be detected
immunochemically at the end of the reaction. Other in catELISA with a Biotin Ligase
vitro screening methods were proposed that use phage Before assessing the colony filter methodologies for the
display [11–13] or cell display technology [14], which screening of enzymatic activities, we performed model
experiments in microtiter plates by using the reaction
schemes of Figure 2 in a catELISA (catalytic enzyme-1Correspondence: neri@pharma.anbi.ethz.ch
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Figure 2. Schematic Representation of the Biotin Ligase (BirA) Ac-
tivity Assay
(A) BirA biotinylates the immobilized biotin acceptor peptide (BAP)
in a buffer supplied with biotin and ATP. The biotinylated peptide
representing the product is detected by a streptavidin-HRP (horse-
radish peroxidase) conjugate.
(B) The fusion protein BirA-CaM-ABD-His6 is immobilized on the
reaction filter, which is coated with human serum albumin (HSA).
The substrate peptide, linked to a high-affinity calmodulin binding
peptidic moiety, is then added to BirA-CaM-ABD-His6 and binds to
calmodulin. BirA biotinylates the peptide, and the product is de-
tected with streptavidin-HRP.
ABD (BirA-CaM-ABD-His6), produced in the bacterial cy-
toplasm (Figure 4A). Also, the biotin acceptor peptide,
fused to glutathione S-transferase (GST-BAP), was ex-
pressed in E. coli and purified on a glutathione resin
(Figure 4B).
We used two different approaches to assay the activ-
ity of the biotin ligase (Figures 2A and 2B). In the first
approach, the substrate of the reaction (GST-BAP) was
immobilized on a microtiter plate. An ELISA experiment
confirmed that GST-BAP expressed in Escherichia coli
Figure 1. Schematic Representation of the Filter Sandwich Assay was not biotinylated by endogenous biotin ligase (Figure
for a Biotin Ligase 5A; negative control). Mass spectrometry analysis of the
(A) Bacterial colonies expressing enzyme on a hydrophilic filter on fusion protein indicated that a portion of the BAP was
top of a solid medium.
proteolyzed (data not shown). The GST-BAP-coated(B) Bacteria on the master filter release biotin ligase (BirA) to the
wells were blocked with milk and incubated with 5 greaction filter, which is coated with a fusion protein of GST, and the
of BirA-His6 in a reaction buffer supplied with ATP andbiotin acceptor peptide (BAP), which represents the substrate of
the reaction. biotin. Biotinylated GST-BAP, representing the product
(C) Fusion protein of BirA-calmodulin-ABD-His6 is released from of the reaction, was detected with a streptavidin-HRP
the bacteria and immobilized on the human serum albumin (HSA)- conjugate. The results of the catELISA experiment are
coated reaction filter by the noncovalent interaction of the albumin
shown in Figure 5A. A strong signal was obtained whenbinding domain (ABD) and HSA.
either purified BirA-His6 (from clone pCHH20/TG1) or
BirA-CaM-ABD-His6 (from clone pCHH19/TG1) was
added to the reaction. Negative controls in which nolinked immunosorbent assay) format [10]. The catELISA
experiment is a simplification of the enzyme filter colony enzyme was added, ATP or biotin was omitted in the
reaction buffer, or the wells were coated with GST in-screening method; the reaction is performed in physi-
cally separated reaction compartments, and purified en- stead of GST-BAP were performed. All negative controls
showed significantly lower signals, confirming that thezyme or enzyme-fusion protein is used. This experiment
allows the assessment of the integrity and functionality BirA-mediated biotinylation reaction is specific.
In the second approach (Figure 2B), BirA-CaM-ABD-of the components of the reaction schemes of Figures
1 and 2, namely the integrity of enzymes, reaction sub- His6 (5 g per well) was immobilized on a microtiter plate
coated with human serum albumin (HSA).strates, and binding molecules.
We purified to homogeneity BirA-His6 (Figure 3) and The peptidic reaction substrate GAAARWKKAFIAV
SAANRFKKISTSGGGPGGLVSIFEAQKIEWH containingthe fusion proteins consisting of BirA, calmodulin, and
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Figure 4. SDS-PAGE Analysis of Proteins Expressed in the Cyto-
plasm of E. coli
(A) Lane 1: molecular-weight marker. Lane 2: hexa-histidine-tagged
BirA (from pCHH20/TG1) purified by nickel affinity chromatography.
Lane 3: hexa-histidine-tagged fusion protein of BirA, calmodulin,
and albumin binding domain (from pCHH19/TG1) purified by nickel
affinity chromatography.
(B) Lane 1: molecular-weight marker. Lane 2: biotin acceptor protein
(BAP) fused to the C terminus of GST via an 8 amino acid linker
(from pCHH21/TG1) purified by glutathione sepharose affinity chro-
matography.
tion does not take place with the BirA-CaM-ABD-His6
fusion protein, in spite of the fact that this enzyme is
catalytically active (Figure 5A). This may be due to the
relatively short linkers between calmodulin/BirA (13
amino acids; GGSGGGGSGGGGS) and calmodulin/BAP
(8 amino acids; TSGGGPGG). However, the intramolecu-
lar reaction of Figure 5B (bar 3) gave a weak ELISA
Figure 3. Vectors for the Cytoplasmic Expression of BirA signal when the reaction was allowed to proceed for 3
hr at 37C, yet the signal was significantly lower than(A) Hexa-histidine-tagged BirA.
(B) Hexa-histidine-tagged BirA-calmodulin-ABD fusion protein. the positive control. The ELISA signal does not increase
ABD stands for albumin binding domain; amp stands for ampicillin when a fusion protein with a 40 amino acid linker be-
resistance gene; and BirA stands for biotin ligase gene. tween calmodulin and BirA is used [J. Bertschinger and
D.N., unpublished data].
the BAP sequence (underlined) was anchored on cal-
modulin by means of its calmodulin binding moiety Biotin Ligase Activity Detected by Colony
Filter Screening(boldface). The enzyme was allowed to catalyze the re-
action in a buffer supplied with biotin and ATP, before We then investigated whether the two strategies de-
picted in Figure 2 could be performed by a modifiedthe formation of reaction product was detected with
streptavidin-HRP conjugate. Control reactions were screening methodology based on the two-membrane
colony filter screening system of Skerra [18]. Bacterialperformed as follows. A biotinylated calmodulin binding
peptide [biotin-CAAARWKKAFIAVSAANRFKKIS; (27]) cells harboring a plasmid for the cytoplasmic expression
of BirA-His6 (pCHH20/TG1) or BirA-CaM-ABD-His6 fu-was used as a positive control, simulating the reaction
product of the biotinylation reaction. In negative con- sion protein (pCHH19/TG1) were grown on a porous
master filter, in contact with an agar plate providingtrols, either biotin or the substrate peptide was not
added to the reaction mixture. The ELISA signals of the nutrients to the filter by diffusion. As soon as small colo-
nies were visible, the master filter was laid on a secondindividual reactions are shown in Figure 5B. The positive
control with a biotinylated peptide showed a strong sig- agar plate, containing IPTG for the induction of protein
expression. The activity of the biotin ligase enclosed innal indicating that the binding partners HSA/ABD, cal-
modulin/calmodulin binding peptide, and biotin/strepa- the bacterial cells was assayed via the strategies shown
in Figure 2. In the first approach (Figures 1B and 2A), atividin-HRP are functional and that product can be
detected. However, biotinylation of the substrate pep- second filter (“reaction filter”) was coated with GST-
BAP, incubated in reaction buffer supplied with biotintide could only be detected when additional biotin ligase
(5 g per well) was added to the reaction mixture. These and ATP, and dried carefully with blotting paper. A filter
sandwich was then formed with the semidry reactiondata indicate that the intramolecular biotinylation reac-
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the region where it was covered by bacterial colonies
expressing the enzyme. Importantly, the biotin ligase
released by the bacterial colonies did not diffuse,
allowing the identification of individual colonies carrying
the desired enzymatic activity. As a negative control,
the filter was either coated with GST without the BAP,
or TG1 E. coli cells that harbor the ampicillin resistance
gene but that do not overexpress BirA were used (Figure
6A, middle and right filters). Biotinylation of the substrate
by endogenous BirA protein was not detectable be-
cause of its low abundance and the competitive inhibi-
tion of the biotin carboxyl carrier protein.
In the second approach (Figures 1C and 2B), a filter
sandwich was formed with the master filter and a reac-
tion filter coated with human serum albumin. The master
filter was covered with bacterial colonies, expressing
BirA-CaM-ABD-His6 in the cytoplasm. The fusion protein
was released from the cells by freezing and thawing of
the filter sandwich, allowing their noncovalent immobili-
zation on the reaction filter by interaction with HSA.
The reaction filter was then washed, and the substrate
peptide GAAARWKKAFIAVSAANRFKKISTSGGGPGG
LVSIFEAQKIEWH was added to the reaction filter,
allowing its binding to the calmodulin moiety of BirA-
CaM-ABD-His6 by means of the calmodulin binding pep-
tidic sequence (boldface) [11]. The reaction filter was
incubated in reaction buffer supplied with biotin and
ATP, and the resulting product was detected as in the
first approach (see above). Control reactions were per-
formed with biotinylated peptide (biotin-CAAARWK
KAFIAVSAANRFKKIS as positive control), no peptide
(first negative control), an irrelevant peptide (GGHRDYKFigure 5. catELISA Experiments in which the Two Different Assay
DEGGGAAARWKKAFIAVSAANRFKKIS; second nega-Formats from Figure 2 Were Used
tive control) or no biotin (third negative control). The(A) lane 1, no enzyme was added to the reaction (negative control
results are shown in Figure 6B; the presence of a biotin-1); lane 2, BirA-His6 was added to the reaction mixture; lane 3,
ylated peptide is detected in the positive control (leftBirA-calmodulin-ABD-His6 fusion protein was added to the reaction
mixture; lane 4, BirA-His6 was added to the reaction mixture, devoid filter) and in the enzyme-catalyzed reaction (middle fil-
of biotin (negative control 2); lane 5, BirA-His6 was added to the ter), but not in the negative controls (right filter; first
reaction mixture, devoid of ATP (negative control 3); lane 6, BirA- negative control only is shown; similar pictures were
His6 was added to the reaction mixture, but the microtiter well was obtained with the other two negative controls). The reac-
coated with GST (negative control 4).
tion filters of the positive control gave slightly stronger(B) lane 1, no BirA-calmodulin-ABD-His6 fusion protein was added
signals, in spite of the X-ray film being exposed for a 40-to the reaction mixture (negative control 1); lane 2, BirA-calmodulin-
fold shorter time. This corresponds to an approximatelyABD-His6 fusion protein and biotinylated peptide were added to the
reaction mixture (positive control); lane 3, BirA-calmodulin-ABD-His6 100-fold lower degree of biotinylation in the enzyme-
fusion protein and substrate peptide were added to the reaction catalyzed reaction, which was, however, clearly positive
mixture; lane 4, BirA-calmodulin-ABD-His6 fusion protein and sub- compared to the negative controls, in which no signal
strate peptide were added to the reaction mixture, and soluble BirA- was detectable.
His6 was also added; lane 5, BirA-calmodulin-ABD-His6 fusion pro- The fact that the intramolecular enzyme-catalyzed re-tein and substrate peptide were added to the reaction mixture,
action gives a weaker signal, compared to that of thedevoid of biotin (negative control 2); lane 6, BirA-calmodulin-ABD-
positive control, is in line with the results of model selec-His6 fusion protein and substrate peptide were added to the reaction
mixture, devoid of ATP (negative control 3). See also the Results tion experiments performed with phage-displayed BirA-
and Experimental Procedures sections. CaM fusion proteins [15]. In comparison to the catELISA
performed on microtiter plates (Figure 5B), the reaction
with BirA-CaM-ABD-His6 can comfortably be detected
filter and the master filter on top. Freezing and thawing in the filter screening assay (Figure 6B). This could be
the filter sandwich three times released the biotin ligase due to the more sensitive detection method used (ECL)
from the cells, and the biotin ligase was allowed to bio- or to a higher surface density of immobilized BirA-CaM-
tinylate the biotin acceptor peptide on the reaction filter ABD-His6/peptide complex, allowing an intermolecular
at 37C. The filter was then washed, and product forma- reaction.
tion was detected with streptavidin-horseradish peroxi-
dase and a chemiluminescent substrate. Figure 6A Discussion
shows an image of the reaction filter (left) obtained ac-
cording to the protocol outlined above. The biotin ac- We describe two novel methodologies for the isolation
of enzymatic activities from a large repertoire of enzymeceptor peptide coated on the filter is biotinylated in
Screening for Enzyme Activities
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Figure 6. Two Different Filter Sandwich Activity Assays for the Biotin Ligase
The figure shows X-ray films, which were exposed to the reaction filters treated with streptavidin-HRP and the chemiluminescence ECL
detection kit. The schematic drawing above each film illustrates the reaction conditions.
(A) Left filter, BirA-His6 released from bacterial cells biotinylates the BAP in the presence of biotin and ATP (1 min exposure time); middle
filter, the reaction filter is coated with GST that does not have a BAP fused to it (negative control 1; 1 min exposure time [the same filter was
still negative for exposures as long as 30 min]); right filter, bacteria do not express biotin ligase (negative control 2; 1 min exposure time).
(B) Left filter, BirA-calmodulin-ABD-His6 is released from the bacterial cells, and biotinylated peptide is added to the reaction (positive control;
30 s exposure time); middle filter, substrate peptide is added to the reaction (exposure time: 20 min); right filter, no peptide is added to the
reaction (exposure time: 20 min). For further details, see the Results section.
mutants based on a filter-sandwich assay. The two- semidry reaction conditions. Product detection in the
filter sandwich assay turned out to be much more sensi-membrane colony screening system was initially devel-
oped for screening antibody Fab fragments secreted by tive than in the catELISA activity assay performed in
microtiter plates, with an excellent signal to backgroundbacterial colonies for binding to an antigen [16, 18].
Giovannoni et al. have recently used it to isolate good- ratio.
In the second experimental approach (Figures 1C andquality antibodies by screening a large (108 clones)
naı¨ve library of human antibody fragments by iterative 2B), in which a calmodulin-tagged enzyme is captured
on the reaction filter and is allowed to react with a cal-colony filter screening [19]. We reasoned that one could
modify this technology to screen for enzyme activities modulin binding substrate derivative, the reaction prod-
uct could only be identified in the filter sandwich assayrather than for antibody binding.
The first experimental strategy (Figures 1B and 2A), but not in the catELISA experiments in microtiter plates.
This observation may be due to a steric hindrance ofin which a soluble enzyme converts substrates into
products, which are attached to the reaction filter, pro- the intramolecular biotinylation or to a more favorable
reaction in trans occurring in the reaction filter becauseceeds with minimal diffusion of the released enzyme
from the bacterial colony, allowing the identification of of a very high-density protein coating. It is likely that a
longer linker between the substrate peptide and thecatalytically active colonies. Diffusion of the enzyme
in the filter sandwich was successfully prevented by enzyme, or between enzyme and calmodulin, could fa-
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ylated via the N-terminal cysteine by the use of biotin-NHS (Sigma,vor the intramolecular reaction and further increase the
Buchs, Switzerland) and purified by HPLC. Peptide identity wasscope of the methodology. This experimental approach
confirmed by amino acid analysis and by MALDI-TOF (Protein Ser-(Figure 1C) is possibly more interesting than the first
vice Labor, ETH Zu¨rich).
one (Figure 1B) for the following reasons. The noncova- Ampicillin and IPTG were purchased from Applichem (Darmstadt,
lent, but stable, immobilization of the enzyme on the Germany). All the restriction enzymes and polymerases were pur-
reaction filter serves to separate it from other enzymes chased from Qbiogene (Basel, Switzerland), Axon Lab (Baden, Swit-
zerland), and Boehringer Mannheim (Rotkreuz, Switzerland). T4 DNAreleased by the E. coli cells, which could interfere with
ligase was obtained from Qbiogene (Basel, Switzerland). DNA prim-the reaction of interest. Furthermore, less stable sub-
ers were purchased from Microsynth (Balgach, Switzerland).strate derivatives (e.g., proteolytically labile peptides)
can be added to the reaction filter in the absence of
Bacterial Strains and Expression Vector Constructionbacterial colonies and interfering proteins and thereby
All expression work was performed in E. coli strain TG1 [K12, (lac-
reduce the background of unwanted reactions. pro), supE, thi, hsdD5/FtraD36, proAB, lacIq, lacZM15].
The plasmid vectors were constructed by standard techniques
Significance [31].
pVG1 is a vector for periplasmic expression of hexa-histidine-
tagged BirA. The BirA gene was amplified from pGEX-BirA (a kindThe isolation of novel enzymes with improved catalytic
gift of Professor Petri Saviranta, University of Turku, Finland; [21])properties and/or improved substrate specificities is
with the primers birasfiba and birahisnotfo and inserted into the SfiIa major challenge in protein engineering and has pro- and NotI sites of the expression vector pDN255 [32].
found implications for the understanding of how en- pVG3 is a vector for periplasmic expression of the hexa-histidine-
zymes work and for advanced industrial applications. tagged fusion protein BirA-CaM-ABD. The gene for BirA was ampli-
Representing just one example taken from the re- fied from pGEX-BirA with the primers birasfiba and biralinkfo. The
genes for CaM and ABD were amplified from pSD4 [11] and pSB423search activity of our group, human enzymes with
(a kind gift of Professor Mark Suter, University of Zurich, Switzerland;novel substrate specificity, which maintain their cata-
[25]), with the primer pairs linkba/camfonot and camlinkabpba/lytic activity in serum, are urgently needed for effective
abphisnotfo, respectively. The PCR products were assembled in a
tumor targeting [28]. The antibody-mediated delivery three-way PCR assembly reaction with birasfiba and abphisnotfo
of such enzymes to the tumor environment will allow as pull-through primers and inserted into the SfiI and NotI sites of
the selective generation of drugs from nontoxic pre- the expression vector pDN255.
pCHH20 (Figure 3A), a vector for cytoplasmic expression of hexa-cursors (“pro-drugs”) in situ and therefore spare nor-
histidine-tagged BirA, was made by insertion of E. coli BirA, whichmal tissues and improve the therapeutic index of avail-
was PCR amplified with the primers birecoba and hisbglfo and li-able chemotherapeutic agents [29]. Recombinant DNA
gated into the EcoRI and BglII sites of pFV46.3 [33], a pQE12-basedmethodologies allow the facile generation of very large
vector.
repertoires of clones, expressing different enzyme pCHH19 (Figure 3B) is a plasmid for the cytoplasmic expression of
mutants. However, general methodologies for the effi- the hexa-histidine-tagged fusion protein BirA-CaM-ABD. The fused
cient screening of millions of enzymatic activities are genes of BirA, CaM, and ABD were amplified from pVG3 with the
primer pair birecoba/hisbglfo and were inserted into the EcoRI andstill missing. We now describe two novel methodolo-
BglII restriction sites of pFV46.3.gies for the isolation of enzymatic activities from a
pCHH21 is a vector for the production of GST-BAP. The 5 end-large repertoire of enzyme mutants based on a filter-
phosphorylated primers gstpepbirba and gstpepbirfo were assem-sandwich assay. In brief, the enzyme of interest is
bled and ligated into the BamHI and XbaI sites of pGEX-BirA.
expressed in the cytoplasm of Escherichia coli cells,
growing on top of a porous master filter. The enzyme DNA Primers
is released to a second filter (reaction filter) in close The following primers were used: birahisnotfo 5-CCATTGCGG
contact to the master filter, allowing the catalytic con- CCGCTATCAGTGATGGTGATGGTGATGGCCACCTTTTTCTGCAC
TACGCAGGGATATTTC-3; biralinkfo 5-CACCGCCACCAGAACCversion of substrates into products and their conse-
ACCTTTTTCTGCACTACGCAGGGATATTTC-3; camlinkabpba 5-quent detection with product-specific affinity re-
GTACAAATGATGACAGCAAAGGCCGCGttagctgaaGCTAAAGTCTagents. Biotin ligase (BirA) was used as a model to
TAgc-3; abphisnotfo 5-CATTGCGGCCGCTATCAGTGATGGTGATdemonstrate the feasibility and usefulness of the
GGTGATGGCCACCAGGTAATGCAGCTAAAATTTC-3; hisbglfo 5-
methodology. However, this method should be gener- ACTAGATCTCTATCAGTGATGGTGATGGTG-3; cambabam 5-GGA
ally applicable to all catalyzed reactions in which the GCAGGCGCCGGATCCATGGCTGACCAACTGACAGAAGAG-3; bi-
enzyme can be expressed in bacteria and in which the recoba 5-ATCGAATTCATTAAAGAGGAGAAATTAACTATGAAGGAT
AACACCGTGCCAC-3; gstpepbirba 5-GATCCGGCCTGGTTTCTAsubstrate can be chemically modified with a linker arm
TCTTCGAAGCTCAGAAAATCGAATGGCACTGATAGT-3; gstpepbirfo[11]. Several classes of enzymes, for example prote-
5-CTAGACTATCAGTGCCATTCGATTTTCTGAGCTTCGAAGATAGases, esterases, ligases, transferases, polymerases,
AAACCAGGCCG-3; birasfiba 5-ATGCGGCCCAGCCGGCCATGGand aldolases [11–13, 15], should be compatible with
CCATGAAGGATAACACCGTGCCAC-3; linkba, 5-ACCGCCACTTC
the methodologies presented in this article. Eventu- CACCGCCACCAGAACCACCGTTGGCAG-3; camfonot, 5-CCGAT
ally, the usefulness of the these methodologies will TGCGGCCGCCTTTGCTGTCATCATTTGTACA-3.
heavily rely on the availability of good-quality affinity
reagents (e.g., monoclonal antibodies [30] that can Expression and Purification of Protein
Five milliliter overnight cultures of E. coli strain TG1 containing thediscriminate between reaction products and sub-
expression vectors were used for the inoculation of 400 ml of 2YTstrates [11, 15].
media containing 100 g/ml ampicillin. Cells were grown at 37C
with vigorous shaking until an OD600 of 0.6 was reached. ProteinExperimental Procedures
expression was induced by the addition of IPTG to a final concentra-
tion of 1 mM. Cells were incubated for an additional 12 hr at 25CChemicals and Reagents
and then harvested. Proteins that were directed to the periplasmPeptides were synthesized by solid phase chemistry and purified
by HPLC as described [27]. The positive-control peptide was biotin- by the PelB leader sequence (pVG1 and pVG3) were isolated by
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extraction of the periplasmic fraction as described [34]. A modified Colony Filter Assay
Bacteria were grown in liquid 2YT medium containing 100 g/mlextraction buffer (50 mM Tris-HCl [pH 8], 300 mM NaCl, 1 mM EDTA,
10 mM imidazole, and 1 mg/ml polymyxin), compatible with nickel ampicillin until an OD600 of 0.6 was reached. The bacteria were
spread on a 4.7 cm diameter PVDF Durapore membrane filter (typeaffinity chromatography purification, was used. Proteins that had a
hexa-histidine-tag and were expressed into the cytoplasm (pCHH19 GVWP, 0.22 m; Millipore, Bedford, MA, USA), which was placed
on a Petri dish containing 2YT agar with 100 g/ml ampicillin. Theand pCHH20) were lysed with a buffer containing 50 mM Tris-HCl
(pH 8), 300 mM NaCl, 1 mM EDTA, 10 mM imidazole, and 0.2 mg/ plate was incubated at room temperature overnight. The PVDF Dura-
pore membrane filter (master filter) was then placed onto a newml lysozyme. Cells were additionally sonicated. The native fraction of
the expressed protein was purified by nickel affinity chromatography Petri dish containing 2YT agar with 100 g/ml ampicillin and 1 mM
IPTG and incubated at room temperature overnight.with 300l of Ni-NTA agarose (Qiagen, Hilden, Germany). The lysate-
Ni-NTA mixture was loaded into a column (Biorad, Glattbrugg, Swit- A second membrane (reaction filter) was coated with either GST-
BAP or HSA, depending on whether the approach shown in Figurezerland) and washed twice with 6 ml of a buffer containing 50 mM
Tris-HCl (pH 8), 300 mM NaCl, and 15 mM imidazole by gravity flow. 1B or 1C was followed. The 5 cm diameter PVDF membrane (Immo-
The enzyme was eluted in 600 l buffer containing 50 mM Tris-HCl bilon-P; Millipore, Bedford, MA, USA) was incubated in GST-BAP
(pH 8), 300 mM NaCl, and 250 mM imidazole. Expression yields for (0.5 mg/ml) or HSA (1 mg/ml) in PBS at room temperature overnight.
cytoplasmic expression were 1 mg per liter culture for both the BirA- The filter was washed three times with TBST and blocked in 1%
His6 and the BirA-CaM-ABD-His6 protein. Periplasmic expression milk/TBS for 1 hr at room temperature. The GST-BAP-coated filter
(from pVG1/TG1 and pVG3/TG1) yielded very low amounts of protein was additionally incubated in reaction buffer (50 mM Tris-HCl [pH
(0.1 mg/liter culture). 7.4], 100 mM NaCl, 12 mM MgCl2, 10 mM ATP, 100 M D-biotin, 1
Cells expressing the protein GST-BAP into the cytoplasm mg/ml pyrophosphatase, and 0.1% v/v Tween-20) for 10 min at
(pCHH21) were lysed with PBS (20 mM NaH2PO4, 30 mM Na2HPO4, room temperature.
and 100 mM NaCl [pH 7.4]) containing 0.2 mg/ml lysozyme. Cells The coated reaction filters were then placed into an empty Petri
were additionally sonicated. The protein was purified by glutathione dish and covered with the master filter, with the bacterial colonies
sepharose affinity chromatography (Amersham Pharmacia Biotech, on top. The resulting “sandwich” was frozen and thawed three times
Uppsala, Sweden) with 200l of slurry per mg of protein. The protein in order to lyse the cells and to release the expressed protein.
was eluted with PBS containing 20 mM GSH (Sigma, Buchs, Swit- The filter “sandwich” with the GST-BAP-coated reaction filter was
zerland). incubated for 1 hr at 37C to allow the released BirA enzyme to
All proteins were analyzed by SDS polyacrylamid gel electropho- biotinylate the BAP. The HSA-coated reaction filter on which the
resis with precast 10% Bis-Tris gels (Invitrogen, Basel, Switzerland) released fusion protein BirA-CaM-ABD-His6 was immobilized was
and Coomassie staining. The presence of the biotin acceptor pep- washed, blocked in 1% milk/TBSC, and incubated with of 108 M
tide (BAP) fused to GST was analyzed by MALDI-TOF (Protein Ser- preblocked substrate peptide for 30 min at room temperature. Un-
vice Labor, ETH Zu¨rich, Switzerland). bound peptide was removed by being washed three times with
TBSCT before the filter was incubated in reaction buffer (50 mM
catELISA Experiments Tris-HCl pH 7.4, 100 mM NaCl, 12 mM MgCl2, 2 mM ATP, 100 M
Falcon Flexible Assay plates with 96 wells (Becton Dickinson, Hei- D-biotin, 1 mg/ml pyrophosphatase, and 0.1% v/v Tween-20) for 1
delberg, Germany) were coated with GST-BAP protein (50 g per hr at 37C. The biotinylated BAP, which represents the reaction
well) in PBS (pH 7.4; 100 l) at 37C overnight. The wells were product, was detected as follows. The reaction filter was washed
washed four times with TBST (Tris-HCl [pH 7.4], 100 mM NaCl, and four times with TBSCT and blocked for 30 min in 1% milk/TBSC.
0.1% v/v Tween-20) and blocked with 1% milk (Rapilait, Migros, HRP-streptavidin conjugate in 1% milk/TBSC (1:1000) was added
Switzerland) in PBS for 1 hr at room temperature. BirA-His6 (5 g) to the filter and incubated for 30 min at room temperature. The
was then incubated in 100 l of the reaction buffer (50 mM Tris-HCl reaction filter was washed five times with TBSCT, and the bound
[pH 7.4], 100 mM NaCl, 12 mM MgCl2, 10 mM ATP, 100 M D-biotin HRP was identified in a chemiluminescent reaction with the ECL kit
[Sigma, Buchs, Switzerland], 1 mg/ml pyrophosphatase [Sigma, from Amersham Pharmacia Biotech.
Buchs, Switzerland], and 0.1% v/v Tween-20) for 2 hr at 37C. In
negative control reactions, either biotin or ATP was omitted in the
Received: August 8, 2001
reaction buffer. Apyrase (40 g per well; Sigma, Buchs, Switzerland)
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was added to the negative control reaction when ATP was omitted.
Accepted: January 8, 2002The wells were washed four times with TBST and blocked with 1%
milk in TBS for 30 min at room temperature. Then 100 l of pre-
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